Figure 2.

Clinical goals for the use of anti-HIV Abs vary according to (A) mechanisms of viral exposure/infection at the time of administration, and (B) the viral events which therapeutic Abs seek to inhibit among indicated use prior to exposure (green), as postexposure prophylaxis or treatment of acute infection (yellow), and for treatment of chronic infection (red).